Index
Checking point of information
at the time of initial public offering.
AI Analysis
■AI Analysis
AI statistically analyzes IPO information to identify trends.
The closer the number is to 5, the higher the rate of increase in the initial price relative to the offering price.
| popularity | scale-criteria | offering-criteria | exchange-criteria | market-condition | Business-criteria |
| 1 | 2 | 3 | 5 | 5 | 1 |
*This is an analysis of trends and does not guarantee any results.
This is not a solicitation to buy or sell stocks, nor is it investment advice.
*Please check the disclaimer for details.
■AI Analysis Chart
A group of stocks listed in the past
with similar IPO condition trends
| Name | Rate of change
(Inicial Price) |
|
| +6.2% |
|
| +0.0% |
|
| +0.0% |
|
| -7.7% |
|
| -7.5% |
|
| -11.3% |
CompanyOverview
- Company Name：Cuorips Inc
- Business：再生医療等製品、特定細胞加工物の研究、開発、製造、販売再生医療等製品、特定細胞加工物に係る受託開発製造サービス及びコンサルティング業務.
- The industry sector is Pharmaceutical.
- Scheduled to be listed on TSE-Growth.
- The company size is that assumed market capitalization is
approx. 91 Million JPY (excluded public offering), approx. 118 Million JPY (included public offering).
- The lead manager is 野村.
https://cuorips.co.jp/
Initial Public Offering Memo
■ Market Cap | Offering rate | Dilution rate | lock-up information
- The company size is assumed market capitalization is
approx. 91 Million JPY (excluded new issues), approx. 118 Million JPY (included new issues).
- The total amount of new issues is 26.5 Million JPY.
- The total amount of public offering is 12.9 Million JPY.
- The dilution ratio from the new issues is 29%.
- Rate of offering is aprrox. 14%.
- The number of outstanding shares is 5,857,916 shares (excluded new issues),
7,557,916 shares (included new issues).
- The number of diluted shares for stock acquisition rights is 507,950 shares.
- Date of 90-day lockup release (initially scheduled) is September 24, 2023.
- Date of 180-day lockup release (initially scheduled) is December 23, 2023.
■ Book building schedule | Payment schedule
- Book building Period *1：June 9, 2023(Fri.) - June 15, 2023(Thu.)
- Priced date *2 ：June 16, 2023(Fri.)
- Payment Period *3 ：June 19, 2023(Mon.) - June 22, 2023(Thu.)
- Listing Date ：June 27, 2023(Tue.)
*1:(Period for applying lottery to obtain the right to purchase)
*2:(The date when the purchase price is determined)
*3:(Period for expressing your intent to purchase and payment,if you are selected in the lottery)
■ Detail of new issue or public offering
- Unit of application：100 shares (Minimum deposit amount is 156,000 JPY.)
- Assumed issue price：1560 JPY
- Tentatively price range：1400 JPY - 1560 JPY
- Public offering price：1560 JPY
- The initial price on listed：1680 JPY(＋7.7％)
- Newly Issued Shares：1,700,000 shares (Domestic：1,122,500 shares ＋ Overseas：577,500 shares)
- Public offering shares：830,000 shares (Domestic：660,100 shares ＋ Overseas：169,900 shares)
- Number of domestic unit：17,826 Unit
- The lead manager is 野村證券.
- The another securities companies are ＳＢＩ証券/松井証券.
■ New issue or public offering - condition history
|
Update
date |
Assumed issue
price
(JPY) |
Tentatively
price range
(JPY) |
Public offering
price
(JPY) |
| Initial | 2023-05-23 | 1560 JPY | | |
| Application period | 2023-06-08 | | 1400 - 1560 JPY | |
| Priced | 2023-06-16 | | | 1560 JPY |
|
Update
date |
New issues
total shares |
New issues
(Overseas) |
PO&OA
total shares |
PO
(Domestic) |
PO
(Overseas) |
OA
(Domestic) |
OA
(Overseas) |
| Initial | 2023-05-23 | 1,700,000 | 0 | 830,000 | 500,000 | 0 | 330,000 | 0 |
| Application period | 2023-06-08 | 1,700,000 | 0 | 830,000 | 500,000 | 0 | 330,000 | 0 |
| Priced | 2023-06-16 | 1,700,000 | 577,500 | 830,000 | 330,100 | 169,900 | 330,000 | 0 |
※：( ) indicates the breakdown.
e.g. In the case of a PO(overseas), there are domestic and overseas allotments of the public offering, of which the overseas allotment is indicated.
PO : Public offering OA : Over allotment
